Prospective evaluation of GFAP point-of-care testing for rapid diagnosis of glioblastoma. Blums K, Kalra LP, Nerntengian N, Zylyftari S, et al. J Neurooncol 2026;177:22.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blums K, Kalra LP, Nerntengian N, Zylyftari S, et al. Prospective evaluation of GFAP point-of-care testing for rapid diagnosis of glioblastoma. J Neurooncol 2026;177:22.
PMID: 41762323